This June, Mr. Phil Kearney will be joining World Vaccine Congress Asia 2013 and will be speaking on the topic "In-licensing pipeline candidates and innovative work to enhance vaccine research and portfolio in the biological space". His talk will cover Merck's licensing model and interests, as well as how implementing in-licensing can act as a strategy to develop innovative vaccines for unmet medical needs. He will also assess opportunities for external research and licensing in the Asia- Pacific region.
Mr. Kearney is currently the Director of Licensing and External Research at MSD, Australia. Prior to joining Merck, he worked in numerous small to medium biotech companies and held project and executive management positions. He also headed the Research Laboratory in one of Australia's leading Haematology Departments.
Join us at the World Vaccine Congress Asia 2013 held from the 17th – 20th of June 2013 at Grand Copthorne Waterfront Hotel, Singapore. Don't miss out on this highly anticipated event! Register here to attend now!